Venture Life acquires trio of products from Helsinn

11 August 2021 - Deborah Wilkes

Premium

Self-care group Venture Life has acquired a trio of oncology support products, including Gelclair, from Switzerland’s Helsinn Healthcare in a deal worth CHF6.0 million (USD6.5 million).

Click tags below for more information on topics:

Venture Life

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: